| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.8B | $16.7B | $3.8B | $3.6B | $3.3B | $2.8B | $2.5B | $2.3B |
| Cost of Revenue | $8.6B | $8.2B | $7.7B | $7.0B | $6.3B | $5.5B | $4.8B | $4.5B |
| Gross Profit | $9.2B | $8.6B | $2.0B | $1.9B | $1.7B | $1.5B | $1.3B | $1.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.7B | $5.3B | $4.9B | $4.4B | $4.1B | $3.7B | $3.5B | $3.2B |
| Operating Income | $3.5B | $3.3B | $0.7B | $0.7B | $0.7B | $0.5B | $0.4B | $0.4B |
| Net Income | $2.5B | $2.4B | $0.6B | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B |
| EPS (Basic) | $2.98 | $40.91 | $9.33 | $8.45 | $7.71 | $5.45 | $4.29 | $3.76 |
| EPS (Diluted) | $2.97 | $40.66 | $9.26 | $8.37 | $7.64 | $5.40 | $4.25 | $3.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.5B | $14.9B | $13.9B | $12.6B | $11.7B | $11.6B | $10.7B | $8.0B |
| Current Assets | $6.7B | $5.8B | $5.6B | $5.0B | $4.5B | $4.5B | $3.8B | $3.5B |
| Cash & Equivalents | $0.2B | $0.1B | $0.3B | $0.1B | $0.4B | $0.5B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $8.8B | $8.3B | $7.7B | $7.1B | $5.9B | $5.3B | $4.5B | $3.9B |
| Stockholders' Equity | $-0.8B | $-1.4B | $-1.7B | $-1.1B | $-0.1B | $0.1B | $0.4B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.8B | $3.0B | $3.0B | $3.1B | $3.2B | $2.8B | $1.7B | $1.7B |
| Investing Cash Flow | $-1.2B | $-1.2B | $-1.0B | $-0.7B | $-0.6B | $-0.6B | $-0.8B | $-0.5B |
| Capital Expenditures | $1.2B | $1.0B | $1.0B | $0.6B | $0.4B | $0.5B | $0.6B | $0.5B |
| Financing Cash Flow | $-1.5B | $-2.0B | $-1.9B | $-2.7B | $-2.7B | $-1.8B | $-0.9B | $-1.2B |